A small in vivo series (n = 3) reported on NGAL levels in the ultrafiltrate of patients with AKI taking citrate-based CVVH; the clearance of NGAL was low, and the inlet concentration of NGAL over 24 hours of CVVH did not decline [17]. The gene discussed is LCN2; the disease is acute kidney injury.